Online inquiry

IVTScrip™ mRNA-Human ANAPC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19672MR)

This product GTTS-WK19672MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANAPC5 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001137559.1
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51433
UniProt ID Q9UJX4
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANAPC5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19672MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16002MR IVTScrip™ mRNA-Human ALDH4A1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ALDH4A1
GTTS-WK21104MR IVTScrip™ mRNA-Human ALDH6A1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ALDH6A1
GTTS-WK7565MR IVTScrip™ mRNA-Human ABHD15, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ABHD15
GTTS-WK15402MR IVTScrip™ mRNA-Human ALDH4A1, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ALDH4A1
GTTS-WK5557MR IVTScrip™ mRNA-Human PBLD, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA PBLD
GTTS-WK16639MR IVTScrip™ mRNA-Human ALPK1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ALPK1
GTTS-WK22197MR IVTScrip™ mRNA-Human ATP5D, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ATP5D
GTTS-WK18451MR IVTScrip™ mRNA-Human AMHR2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AMHR2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW